Incyte Corporation, a Delaware-based biopharmaceutical company, focuses on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology.

- New facility to serve as European base for Incyte’s drug development operations

- Location provides efficient access to key clinical trial experts and institutions
http://investor.incyte.com/phoenix.zhtml?c=69764&p=irol-newsArticle&ID=2034738
Find an actor

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

"Bristol-Myers Squibb to Acquire Celgene for About Billion"

"The combined company will have nine products with more than billion in annual sales"
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn